Mayo Clinic home page [logo]

Search

  • Print
  • Share
close

Share this on...

Share this site with others using one of these sharing tools.

 

Link to this article

To link to this article, paste this block of HTML code onto your webpage.

Guidelines for sites linking to mayoclinic.org

Kidney Transplant

Kidney Transplant Volume and Statistics in Mayo Clinic in Minnesota

Volumes

Total kidney transplants (1963-2008): 3,926
Total living donor kidney transplants (1963-2008): 2,446
Total deceased donor kidney transplants (1967-2008): 1,480

Year Total Transplants Total Living Donor
1999 142 82
2000 185 123
2001 238 192
2002 211 179
2003 250 205
2004 243 170
2005 253 194
2006 237 185
2007 174 137
2008 96 71

Graphs/Charts

  • line graph icon
  • line graph icon
  • * Note on positive crossmatch and ABO incompatible transplant populations

    Our kidney transplant program has expanded to include a unique group patients who would otherwise not be able to receive a living kidney transplant by performing the transplant in those sensitized patients with a positive crossmatch against their donor (by flow cytometry) or are ABO blood group incompatible with their donor. Currently, the graft survival of these types of transplants is lower than the standard group of patients. The major reason for the lower survival is the immunologic barrier that must be overcome for a successful transplant, though the patients typically have multiple other factors such as multiple prior kidney transplants and debility from long-standing kidney disease. While the graft survival of these transplants has improved significantly over the past few years, the current SRTR adjustments do not adequately address the variables that will likely continue to decrease graft survival in this group of recipients. The positive cross-match and ABO-incompatible patients are well informed of the increased risk of graft loss, however in many cases, this protocol represents their only remaining option for transplantation.

    If these types of transplants are excluded, our center-specific graft survival for both 30 days and 1 year is significantly improved. We provide this clarification to our center-specific survival outcomes as we believe the intent of the center-specific report is to allow for evaluation of outcomes of different programs. Our standard kidney transplant population compares favorably to both the expected and average graft survival rates.





    * National average data acquired from the Scientific Registry of Transplant Recipients at www.ustransplant.org.

Terms of Use and Information Applicable to this Site
Copyright ©2001-2008 Mayo Foundation for Medical Education and Research. All Rights Reserved.

.